What the analyst said
UBS analyst Karl Keirstead upgraded Palantir (NASDAQ: PLTR) from Neutral to Buy with a price target of $180.00.
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
PLTR trades at $143. The 19 analysts who set a target in the last 3 months range from $130 to $273, with a median of $250. This $180 target is 28% below the median.
Since the note PLTR has moved +7% (from $134). 12-month window: day 269 of 365, closes on February 26, 2027.
Track record
This call✓ Target reached on August 27, 2026, 7 months after the note. Same target as this firm’s February 3, 2026 note, so it is scored there.
Firm track recordUBS: 83% of its 59 targets at least a year old were reached within 12 months (#6 of 29 firms); on Palantir, 4 of 5. Accuracy ranking →
UBS on Palantir
UBS price targets on Palantir
8 calls from May 6, 2025 to June 16, 2026. The target went from $110 to $200 (+82%). The rating moved from Hold to Buy.
- June 16, 2026Kept the $200 targetBuy$200
- March 18, 2026Target raised from $180 (+11%)Buy$200
- February 26, 2026 This noteUpgraded to Buy, kept the $180 targetBuy$180
- February 3, 2026Target cut from $205 (−12%)Hold$180
- November 4, 2025Target raised from $165 (+24%)Hold$205
- September 9, 2025Kept the $165 targetHold$165
- August 5, 2025Target raised from $110 (+50%)Hold$165
- May 6, 2025Earliest call shownHold$110





